Ideas to action: independent research for global prosperity
Does SDR Recycling Impair Reserve Management?
November 14, 2023
Improving School Management of Violence in Peru
November 22, 2023
Generating and Using Cost Evidence to Inform Provider Payment Rates: Lessons from High-Income Countries for India’s National Health Insurance Program
June 07, 2023
PM-JAY, India’s national health insurance program, is the largest publicly funded health insurance program in the world. It has reformed the way in which the poor and vulnerable access hospital care in India. The size of this program and the inclusion of private providers in delivering care has led ...
Lessons from Expanding Access to COVID-19 Treatments in LMICs through Voluntary Licensing
December 14, 2022
Voluntary licensing agreements can be a powerful tool to facilitate global access to essential medicines—but without careful attention to their features, their impact on access in LMICs will be too little, too late.
Oral Antiviral Treatments for COVID-19: Time to Revisit?
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...
Leveraging Purchasing Systems to Ensure Access, Stewardship, and Innovation: A Landscape Review of Current and Potential Market Structures for Antimicrobials
June 28, 2022
This working paper aims to synthesise existing research and thinking on how antimicrobials are procured and ways to improve the current purchasing system.
Rapid and Equitable Access to Medical Countermeasures: Lessons, Landscape, and Near-Term Recommendations
May 11, 2022
This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks.
Policy Actions for the US Government to Accelerate Access to Oral Antivirals for COVID-19 in Low- and Middle-Income Countries
April 07, 2022
While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...
Expanding Emergency Vaccine Manufacturing Capacity in Latin America and the Caribbean
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...